这是一篇来自已证抗体库的有关
人类 LMO2的综述,是根据10篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合LMO2 抗体。
LMO2 同义词: LMO-2; RBTN2; RBTNL1; RHOM2; TTG2; rhombotin-2; LIM domain only protein 2; T-cell translocation gene 2; T-cell translocation protein 2; cysteine-rich protein TTG-2; rhombotin-like 1
安迪生物R&D
山羊 多克隆 | - 免疫细胞化学; 人类; 图 1c
- 免疫组化; 人类; 图 1e
- 免疫印迹; 人类; 图 1d
| 安迪生物R&D LMO2抗体(R&D, AF2726)被用于被用于免疫细胞化学在人类样品上 (图 1c), 被用于免疫组化在人类样品上 (图 1e) 和 被用于免疫印迹在人类样品上 (图 1d). Oncotarget (2016) ncbi |
山羊 多克隆 | | 安迪生物R&D LMO2抗体(R&D Systems, AF2726)被用于被用于染色质免疫沉淀
在小鼠样品上 (图 4). Exp Biol Med (Maywood) (2016) ncbi |
山羊 多克隆 | | 安迪生物R&D LMO2抗体(R&D systems, AF2726)被用于被用于ChIP-Seq在小鼠样品上 (图 1). Dev Cell (2016) ncbi |
山羊 多克隆 | | 安迪生物R&D LMO2抗体(R&D Systems, AF2726)被用于被用于染色质免疫沉淀
在人类样品上. Blood (2015) ncbi |
山羊 多克隆 | | 安迪生物R&D LMO2抗体(R&D systems, AF2726)被用于被用于染色质免疫沉淀
在人类样品上. Nucleic Acids Res (2014) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(1A9-1) | | 圣克鲁斯生物技术 LMO2抗体(Santa Cruz, sc-65736)被用于被用于ChIP-Seq在人类样品上 (图 3). Oncogene (2016) ncbi |
Novus Biologicals
小鼠 单克隆(1A9-3B11) | - ChIP-Seq; 小鼠; 图 4c
- 免疫印迹; 小鼠; 图 4b
| Novus Biologicals LMO2抗体(Novus Biologicals, NB110-78626)被用于被用于ChIP-Seq在小鼠样品上 (图 4c) 和 被用于免疫印迹在小鼠样品上 (图 4b). Genes Dev (2016) ncbi |
Ventana
小鼠 单克隆(1A9-1) | | Ventana LMO2抗体(Ventana, 1A9-1)被用于被用于免疫组化在人类样品上 (图 1c). Am J Surg Pathol (2018) ncbi |
Roche Applied Science
大鼠 单克隆(SP51) | | Roche Applied Science LMO2抗体(Venatana, SP51)被用于被用于免疫组化-石蜡切片在人类样品上 (图 1e). Histopathology (2017) ncbi |
Spring Bioscience Corp.
兔 单克隆(SP51) | - 免疫组化-石蜡切片; 人类; 1:100; 表 2
| Spring Bioscience Corp. LMO2抗体(Spring Bioscience, SP51)被用于被用于免疫组化-石蜡切片在人类样品上浓度为1:100 (表 2). Histopathology (2016) ncbi |
Moore E, Swerdlow S, Gibson S. Comparison of Myocyte Enhancer Factor 2B Versus Other Germinal Center-associated Antigens in the Differential Diagnosis of B-Cell Non-Hodgkin Lymphomas. Am J Surg Pathol. 2018;42:342-350
pubmed 出版商
Verdanet E, Dereure O, René C, Tempier A, Benammar Hafidi A, Gallo M,
et al. Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas. Histopathology. 2017;71:648-660
pubmed 出版商
Hu Y, Zhang Z, Kashiwagi M, Yoshida T, Joshi I, Jena N,
et al. Superenhancer reprogramming drives a B-cell-epithelial transition and high-risk leukemia. Genes Dev. 2016;30:1971-90
pubmed 出版商
Peckova K, Michal M, Hadravsky L, Suster S, Damjanov I, Miesbauerova M,
et al. Littoral cell angioma of the spleen: a study of 25 cases with confirmation of frequent association with visceral malignancies. Histopathology. 2016;69:762-774
pubmed 出版商
Jiang C, Yu J, Ruan Y, Wang X, Zhao W, Wang X,
et al. LIM domain only 2 over-expression in prostate stromal cells facilitates prostate cancer progression through paracrine of Interleukin-11. Oncotarget. 2016;7:26247-58
pubmed 出版商
Braghini C, Costa F, Fedosyuk H, Neades R, Novikova L, Parker M,
et al. Original Research: Generation of non-deletional hereditary persistence of fetal hemoglobin β-globin locus yeast artificial chromosome transgenic mouse models: -175 Black HPFH and -195 Brazilian HPFH. Exp Biol Med (Maywood). 2016;241:697-705
pubmed 出版商
Goode D, Obier N, Vijayabaskar M, Lie A Ling M, Lilly A, Hannah R,
et al. Dynamic Gene Regulatory Networks Drive Hematopoietic Specification and Differentiation. Dev Cell. 2016;36:572-87
pubmed 出版商
Sotoca A, Prange K, Reijnders B, Mandoli A, Nguyen L, Stunnenberg H,
et al. The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia. Oncogene. 2016;35:1965-76
pubmed 出版商
Krivega I, Byrnes C, de Vasconcellos J, Lee Y, Kaushal M, Dean A,
et al. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping. Blood. 2015;126:665-72
pubmed 出版商
Yun W, Kim Y, Kang Y, Lee J, Dean A, Kim A. The hematopoietic regulator TAL1 is required for chromatin looping between the ?-globin LCR and human ?-globin genes to activate transcription. Nucleic Acids Res. 2014;42:4283-93
pubmed 出版商